This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Siamab Therapeutics, Inc., University of California. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 16,025 
Years Active: 2016
Title: Nancy Hurtado-Ziola: Innovator in Cancer Detection
Introduction
Nancy Hurtado-Ziola is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of cancer detection through her innovative research and development. Her work focuses on the use of sialylated glycans and antibodies for early diagnosis and detection of cancer.
Latest Patents
Nancy holds a patent for "Compositions and methods for detecting cancer." This invention provides sialylated glycans and antibodies that specifically bind to them. The compositions and methods developed by Nancy are useful for the early detection and diagnosis of cancer.
Career Highlights
Throughout her career, Nancy has worked with esteemed institutions such as the University of California and Siamab Therapeutics, Inc. Her dedication to advancing cancer detection technologies has positioned her as a leader in her field.
Collaborations
Nancy has collaborated with notable professionals, including Ajit Varki and Richard B. Schwab. These partnerships have further enhanced her research and contributed to the development of innovative solutions in cancer detection.
Conclusion
Nancy Hurtado-Ziola's contributions to cancer detection through her patented inventions and collaborations highlight her role as a key innovator in the medical field. Her work continues to pave the way for advancements in early cancer diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile